Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus

Citation
Jv. Williams et al., Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus, BR J DERM, 142(3), 2000, pp. 506-508
Citations number
12
Categorie Soggetti
Dermatology,"da verificare
Journal title
BRITISH JOURNAL OF DERMATOLOGY
ISSN journal
00070963 → ACNP
Volume
142
Issue
3
Year of publication
2000
Pages
506 - 508
Database
ISI
SICI code
0007-0963(200003)142:3<506:UOMMIT>2.0.ZU;2-I
Abstract
Paraneoplastic pemphigus (PNP) is a rare autoimmune blistering disease with circulating antibodies that bind the cell surface of the epidermis and oth er non-stratifying epithelia, and immunoprecipitate a complex of four or fi ve proteins (250 kDa, 230 kDa, 210 kDa, 190 kDa and occasionally 170 kDa).( 1.2) Combinations of immunosuppressive agents are usually required to obtai n even partial control of the skin lesions.(3) Mucous membrane lesions are refractory to treatment. We describe a patient with PNP whose skill and ora l lesions are quiescent following treatment with oral mycophenolate mofetil .